DAX20.246 -0,3%ESt504.943 -0,1%Top 10 Crypto16,99 +1,7%Dow43.450 -0,6%Nas20.109 -0,3%Bitcoin98.620 -2,4%Euro1,0505 +0,1%Öl73,25 -0,1%Gold2.645 ±-0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Tesla A1CX3T NVIDIA 918422 Broadcom A2JG9Z Palantir A2QA4J MicroStrategy 722713 Amazon 906866 Rheinmetall 703000 Siemens Energy ENER6Y Bayer BAY001 Apple 865985 Mercedes-Benz Group (ex Daimler) 710000 Volkswagen (VW) vz. 766403 RWE 703712 Deutsche Bank 514000 Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX beendet Handel etwas tiefer -- Wall Street schließt rot -- Umstrukturierung bei SAP: Rund 3.500 Mitarbeiter gehen -- Trump kündigt Milliarden-Investitionen von Softbank an -- Tesla, eBay im Fokus
Top News
Warum das Tesla-Logo bei Cybertruck und Cybercab fehlt: Elon Musk erklärt Warum das Tesla-Logo bei Cybertruck und Cybercab fehlt: Elon Musk erklärt
Mehr Optimismus bei Amazon: KI-Entwicklungen überzeugen Aktien-Analysten Mehr Optimismus bei Amazon: KI-Entwicklungen überzeugen Aktien-Analysten
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Dein Weihnachtsbonus wartet - exklusiv für finanzen.net Nutzer

Halozyme Therapeutics Aktie

NeuKaufenVerkaufen
46,16 EUR +0,66 EUR +1,45 %
STU
48,60 USD +0,56 USD +1,17 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.5,82 Mrd. EUR

KGV17,61Div. Rendite0,00%

WKNA0DLHS

ISINUS40637H1095

SymbolHALO

Halozyme Therapeutics Aktien News

DatumMeistgelesen
PR NewswireConcerned Shareholders of Akanda Corp. Replace a Majority of Akanda's Board of Directors
PR NewswireConcerned Shareholders of Akanda Corp. Replace a Majority of Akanda's Board of Directors
PR NewswireConcerned Shareholders of Akanda Corp. Replace a Majority of Akanda's Board of Directors
PR NewswireHalo Announces Results of Annual General and Special Meeting
PR NewswireHalo Announces Results of Annual General and Special Meeting
PR NewswireHalozyme to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
PR NewswireHalozyme Announces Commercial Launch of TLANDO™, an Oral Treatment for Testosterone Replacement Therapy
PR NewswireHalozyme Completes Antares Pharma Acquisition
PR NewswireHalo Collective's Budega™ Dispensary in Westwood to Open May 27 and Hollywood Planned for June
PR Newswire/C O R R E C T I O N from Source -- Halo Collective Inc./
PR Newswire/C O R R E C T I O N from Source -- Halo Collective Inc./
PR NewswireHalo Collective's BudegaTM Westwood Dispensary to Open May 27
PR NewswireHalo Collective's BudegaTM Westwood Dispensary to Open May 27
PR NewswireHalo Collective to Host Earnings Call Today at 4:15pm EST for First Quarter 2022 Financial Results
PR NewswireHalo Collective to Host Earnings Call Today at 4:15pm EST for First Quarter 2022 Financial Results
PR Newswire/R E P E A T -- Halo Collective Reports First Quarter 2022 Financial Results; Book Value Per Share of $1.65 ($2.12 CAD)/
PR Newswire/R E P E A T -- Halo Collective Reports First Quarter 2022 Financial Results; Book Value Per Share of $1.65 ($2.12 CAD)/
PR NewswireHalo Collective Reports First Quarter 2022 Financial Results; Book Value Per Share of $1.65 ($2.12 CAD)
PR NewswireHalo Collective Reports First Quarter 2022 Financial Results; Book Value Per Share of $1.65 ($2.12 CAD)
PR NewswireHart-Scott-Rodino Waiting Period Expires for Halozyme's Acquisition of Antares Pharma
PR NewswireHalozyme Reports First Quarter 2022 Results
PR Newswire/R E P E A T -- Halo Collective Announces Preliminary Results for North Hollywood Dispensary and Sets Date for Westwood Dispensary Grand Opening/
PR Newswire/R E P E A T -- Halo Collective Announces Preliminary Results for North Hollywood Dispensary and Sets Date for Westwood Dispensary Grand Opening/
PR NewswireHalo Collective Announces Preliminary Results for North Hollywood Dispensary and Sets Date for Westwood Dispensary Grand Opening
PR NewswireHalo Collective Announces Preliminary Results for North Hollywood Dispensary and Sets Date for Westwood Dispensary Grand Opening
PR NewswireHalozyme To Host First Quarter 2022 Financial Results Webcast and Conference Call
PR NewswireHalo Collective Announces Filing of Halo Tek Prospectus and Change in Chief Financial Officer and Board of Directors
PR NewswireHalo Collective Announces Filing of Halo Tek Prospectus and Change in Chief Financial Officer and Board of Directors
PR NewswireHalo Collective unterzeichnet eine Absichtserklärung zur Übernahme der Phytocann Group, einem führenden europäischen Wellness-CBD-Unternehmen
PR NewswireHalo Collective Signs a Letter of Intent to Acquire Phytocann Group, a Leading European Wellness CBD Company
PR NewswireHalo Collective Signs a Letter of Intent to Acquire Phytocann Group, a Leading European Wellness CBD Company
PR NewswireHalo Collective Signs a Letter of Intent to Acquire Phytocann Group, a Leading European Wellness CBD Company
PR NewswireHalo Collective Signs a Letter of Intent to Acquire Phytocann Group, a Leading European Wellness CBD Company
PR NewswireHalo Collective Signs a Letter of Intent to Acquire Phytocann Group, a Leading European Wellness CBD Company
PR NewswireHalo Collective Acquires Dissolve Medical
PR NewswireHALOZYME COMMENCES TENDER OFFER FOR ALL OUTSTANDING SHARES OF COMMON STOCK OF ANTARES PHARMA
PR NewswireHalozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
PR NewswireHalo Collective Announces Westwood Dispensary Completion, Local Inspections Passed, and Planned Opening for Second Budega™ in California
PR NewswireHalo Collective Announces Westwood Dispensary Completion, Local Inspections Passed, and Planned Opening for Second Budega™ in California
PR NewswireHalo Collective Reports 63% Revenue Growth and 345% Cannabis Sales Volume Growth in the Fourth Quarter of 2021

Halozyme Therapeutics News

Halozyme Therapeutics News: auf dieser Seite finden Sie alle Halozyme Therapeutics News und Nachrichten zur Halozyme Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Halozyme Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Halozyme Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.